Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,454.80 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
Nasdaq 2,837.53 -1.85 -0.07%
Ticker Volume Price Price Delta
STOXX 50 2,161.87 +5.35 0.25%
FTSE 100 5,351.53 +1.48 0.03%
DAX 6,339.94 +24.05 0.38%
Ticker Volume Price Price Delta
Nikkei 8,580.39 +17.01 0.20%
TOPIX 722.11 -0.14 -0.02%
Hang Seng 18,713.40 +47.01 0.25%
Gold 1,578.00 +0.43%
EUR-USD 1.2578 0.1816%
Nasdaq 2,837.53 -0.07%
DJIA 12,454.80 -0.60%
S&P 500 1,317.82 -0.22%
FTSE 100 5,351.53 +0.03%
STOXX 50 2,161.87 +0.25%
DAX 6,339.94 +0.38%
Oil (WTI) 91.24 +0.42%
U.S. 10-year 1.738% -0.039
BAC:US 7.15 +0.14%
FB:US 31.91 -3.39%
  • Exchange: ASE
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Whsle Drug Dist

Sigma Pharmaceuticals Ltd

Add to Portfolio

SIP:AU

0.6350 AUD 0.00000.00%

As of 02:10:56 ET on 05/25/2012.

Snapshot for Sigma Pharmaceuticals Ltd (SIP)

Open: 0.6300 Day's Range: 0.6300 - 0.6450 Volume: 886,275 Bid: 0.6350
Previous Close: 0.6350 52wk Range: 0.3662 - 0.7373 1-Yr Rtn: +82.60% Ask: 0.6400

Stock Chart for SIP

No chart data available.
  • SIP:AU 0.6350
  • 1D
  • 1M
  • 1Y
0.6350
Interactive SIP Chart

Previous Close

Key Statistics for SIP

Current P/E Ratio (ttm) 15.1190
Estimated P/E (01/2013) 13.5106
Earnings Per Share (AUD) (ttm) 0.0420
Est. EPS (AUD) (01/2013) 0.0470
Est. PEG Ratio -
Market Cap (M AUD) 752.49
Shares Outstanding (M) 1,185.02
Enterprise Value (M AUD) (ttm) 638.89
Enterprise Value/EBITDA (ttm) 9.02
Price/Book (mrq) 1.0966
Price/Sale (ttm) 0.2580
Dividend Indicated Gross Yield 7.8740
Next Earnings Announcement 09/13/2012
More SIP Key Statistics mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Financials for SIP

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)
More SIP Income Statement Data
  • Total Assets
  • Total Liabilities (M/AUD)
  • Debt to Assets (%)
More SIP Balance Sheet Data
  • Operating
  • Investing
  • Financing (M/AUD)
More SIP Cash Flow Data

Company Profile & Key Executives for SIP

Sigma Pharmaceuticals Limited manufactures, wholesale and distributes prescription, over-the-counter and generic pharmaceutical products. The Company also owns a number of pharmacy banner brands in Australia.

Mark R HooperCEO/Managing DirectorJeffrey Wayne Sells "Jeff"Chief Financial Officer
Gary DunneChief Operating OfficerSue Morgan-DethickSecretary/General Counsel
More Company Profile & Key Executives for SIP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Advertisements